UK and USA-listed PureTech Health has sought to show the strength of its position in idiopathic pulmonary fibrosis (IPF) at ...

The Gilead subsidiary company Kite has entered into a definitive agreement to acquire Interius BioTherapeutics, a privately-held biotechnology company developing in vivo CAR therapeutics, for $350 ...

Exorphia announced that it has signed a business collaboration agreement with fellow Japanese company Rohto Pharmaceutical, following the capital alliance previously established between the two ...